´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 2ÀÏÂ÷ : 2021-09-17±³À°ÀÏÀÚ : 2021-09-17
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5Ãþ ±×·£µåº¼·ë
±³À°ÁÖÁ¦ :
´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 2ÀÏÂ÷ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ
´ã´çÀÚ : ¹éÁöÀº
¿¬¶ôó : 02-3275-5335
À̸ÞÀÏ :
kshf4@kshf.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í ±³¼ö: 70,000¿ø, ÀϹÝÀÇ: 30,000¿ø, Àü°øÀÇ, °£È£»ç, 65¼¼ ÀÌ»ó, Çлý, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ): ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:00~09:20 Introduction of ESC (or HFA) Educational Program Ewa Anita Jankowska(Wroclaw Medical University)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:20~09:35 Current Status and Future Perspective of Educational Program for Cardiologist in Korea ¹ÚÈñ³²(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:35~09:50 Setting Up of Early Career as a HF Specialist ±è°æÈñ(ÀÎõ¼¼Á¾º´¿ø)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:50~10:20 New HFpEF Diagnosis Concept. Is the Classiffication based on Ejection Fraction Kept on? Andrew Coats(Univ of Warwick UK)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 10:20~10:50 Novel or Revisit of Pharmacological Treatment of HFpEF Stefan D. Anker(Charite Campus Virchow Clinic Germany)
Åä·Ð 09-17 ±×·£µåº¼·ë 10:50~11:10 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 09-17 ±×·£µåº¼·ë 11:10~11:20 Short Coffee Break ()
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 11:20~11:35 Practical Management of ECMO in aborted Sudden Cardiac Death ±è¹Î¼®(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 11:35~11:50 Start ECMO in Left Heart Decompression: When, How ? À̼±±â(ÇѸ²ÀÇ´ë)
Åä·Ð 09-17 ±×·£µåº¼·ë 11:50~12:00 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
½Ä»ç 09-17 ±×·£µåº¼·ë 12:00~13:00 Lunch ()
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 13:00~14:00 Brightening Abstract Presentation (I) ()
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:00~14:15 Utilization of Marginal Donors in Heart Transplantation Jon A Kobashigawa(Cedars-Sinai Medical Center USA)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:15~14:30 Current Status of Heart Transplantation and LVAD in Korea ÃÖÁø¿À(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:30~14:45 The Right Ventricle and LVAD Therapy Mandeep R Mehra(Harvard Univ. USA)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:45~15:00 Palliative Management in End Stage HF Patients À̼ö¿ë(ºÎ»êÀÇ´ë)
Åä·Ð 09-17 ±×·£µåº¼·ë 15:00~15:20 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 09-17 ±×·£µåº¼·ë 15:20~15:30 Short Coffee Break ()
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 15:30~15:45 Initial Phenotyping and Therpeutic Decision Making in HFpEF ÃÖÁ¤Çö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 15:45~16:00 Echocardiography for CIED ±è¿ëÁø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 16:00~16:15 Decision Making in Critically Ill Patients ±è´ëÈñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 16:15~16:30 The Use of Echocardiography in Post Heart Transplantation ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë)
Åä·Ð 09-17 ±×·£µåº¼·ë 16:30~17:00 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 09-17 ±×·£µåº¼·ë 17:00~17:10 Short Coffee Break ()
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:10~17:25 Gender specific HF treatment strategy ±èÇзÉ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:25~17:40 RFA of atrial fibrillation and single nucleotide polymorphism ÃÖÁ¾ÀÏ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:40~17:55 Role of precision medicine in pulmonary hypertension Á¤¿íÁø(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:55~18:10 Emerging Roles of Biomarkers in Heart Failure Á¶µ¿Çõ(¿¬¼¼¿øÁÖÀÇ´ë)
Åä·Ð 09-17 ±×·£µåº¼·ë 18:10~18:40 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)